Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Epidermal growth factor receptor inhibition in head and neck cancer--more insights, but more questions.

× No keyword cloud information.

12 in total

Review 1. Immunotherapy of head and neck cancer using tumor antigen-specific monoclonal antibodies.

Authors: Steve C Lee; Andrés López-Albaitero; Robert L Ferris
Journal: Curr Oncol Rep Date: 2009-03 Impact factor: 5.075

2. Epidermal growth factor receptor regulates beta-catenin location, stability, and transcriptional activity in oral cancer.

Authors: Chien-Hsing Lee; Hsing-Wen Hung; Pei-Hsin Hung; Yi-Shing Shieh
Journal: Mol Cancer Date: 2010-03-19 Impact factor: 27.401

3. Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertension.

Authors: Tengis S Pavlov; Vladislav Levchenko; Paul M O'Connor; Daria V Ilatovskaya; Oleg Palygin; Takefumi Mori; David L Mattson; Andrey Sorokin; Julian H Lombard; Allen W Cowley; Alexander Staruschenko
Journal: J Am Soc Nephrol Date: 2013-04-18 Impact factor: 10.121

4. Enterococcus faecalis enhances cell proliferation through hydrogen peroxide-mediated epidermal growth factor receptor activation.

Authors: Kanitsak Boonanantanasarn; Ann Lindley Gill; YoonSing Yap; Vijayvel Jayaprakash; Maureen A Sullivan; Steven R Gill
Journal: Infect Immun Date: 2012-07-30 Impact factor: 3.441

5. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.

Authors: Zohra Tumur; Shahbaz Katebzadeh; Carlos Guerra; Lokesh Bhushan; Tursun Alkam; Bradley S Henson
Journal: Neoplasia Date: 2015-01 Impact factor: 5.715

Review 6. Oncologist's/haematologist's view on the roles of pathologists for molecular targeted cancer therapy.

Authors: Ulrich Keller; Nikolas von Bubnoff; Christian Peschel; Justus Duyster
Journal: J Cell Mol Med Date: 2010-02-16 Impact factor: 5.310

7. MiRNA-125a-5p: a regulator and predictor of gefitinib's effect on nasopharyngeal carcinoma.

Authors: Yanyang Liu; Zhixi Li; Lu Wu; Zi Wang; Xia Wang; Yang Yu; Qian Zhao; Feng Luo
Journal: Cancer Cell Int Date: 2014-03-07 Impact factor: 5.722

8. Changes in cell junctions induced by inhibition of epidermal growth factor receptor in oral squamous cell carcinoma cells.

Authors: Yasumasa Kakei; Shun Teraoka; Masaya Akashi; Takumi Hasegawa; Takahide Komori
Journal: Exp Ther Med Date: 2017-06-14 Impact factor: 2.447

9. Combined effects of bevacizumab with erlotinib and irradiation: a preclinical study on a head and neck cancer orthotopic model.

Authors: A Bozec; A Sudaka; J-L Fischel; M-C Brunstein; M-C Etienne-Grimaldi; G Milano
Journal: Br J Cancer Date: 2008-06-24 Impact factor: 7.640

10. Interaction of EGFR to δ-catenin leads to δ-catenin phosphorylation and enhances EGFR signaling.

Authors: Yongfeng He; Taeyong Ryu; Nensi Shrestha; Tingting Yuan; Hangun Kim; Hridaya Shrestha; Young-Chang Cho; Young-Woo Seo; Woo Keun Song; Kwonseop Kim
Journal: Sci Rep Date: 2016-02-17 Impact factor: 4.379